Published in J Natl Cancer Inst on June 01, 2015
The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer. J Natl Cancer Inst (2016) 0.94
Epidemiologic studies of the human microbiome and cancer. Br J Cancer (2016) 0.91
CtBP1 associates metabolic syndrome and breast carcinogenesis targeting multiple miRNAs. Oncotarget (2016) 0.77
Exploring effects of presurgical weight loss among women with stage 0-II breast cancer: protocol for a randomised controlled feasibility trial. BMJ Open (2016) 0.75
Gut microbiota composition associated with alterations in cardiorespiratory fitness and psychosocial outcomes among breast cancer survivors. Support Care Cancer (2017) 0.75
Influence of Oral and Gut Microbiota in the Health of Menopausal Women. Front Microbiol (2017) 0.75
QIIME allows analysis of high-throughput community sequencing data. Nat Methods (2010) 85.34
Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol (2007) 60.97
A core gut microbiome in obese and lean twins. Nature (2008) 52.30
Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A (2005) 33.66
Structure, function and diversity of the healthy human microbiome. Nature (2012) 30.40
A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature (2012) 11.68
Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A (2010) 11.21
Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics (2006) 7.40
Richness of human gut microbiome correlates with metabolic markers. Nature (2013) 6.93
UniFrac: an effective distance metric for microbial community comparison. ISME J (2010) 6.43
Human genetics shape the gut microbiome. Cell (2014) 4.91
Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA (2004) 4.31
Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst (2004) 3.53
Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. Cancer Res (2003) 2.49
Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol (2011) 2.44
An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform. Microbiome (2014) 2.27
Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer (2011) 2.20
Reduced enterobacterial and increased staphylococcal colonization of the infantile bowel: an effect of hygienic lifestyle? Pediatr Res (2005) 2.07
Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol (2013) 1.93
The intestinal microbiome in early life: health and disease. Front Immunol (2014) 1.90
C-reactive protein and risk of breast cancer. J Natl Cancer Inst (2007) 1.89
Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence. J Clin Oncol (2012) 1.85
Cesarean delivery may affect the early biodiversity of intestinal bacteria. J Nutr (2008) 1.78
Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. N Engl J Med (1982) 1.77
Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women. Arch Intern Med (2007) 1.75
Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study. Breast Cancer Res Treat (2010) 1.70
Molecular pathways: adipose inflammation as a mediator of obesity-associated cancer. Clin Cancer Res (2013) 1.65
Estrogen metabolism and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (2012) 1.53
Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study. Breast Cancer Res (2008) 1.52
Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status. J Natl Cancer Inst (2005) 1.50
Microbiome and malignancy. Cell Host Microbe (2011) 1.45
Assessment of the human faecal microbiota: II. Reproducibility and associations of 16S rRNA pyrosequences. Eur J Clin Invest (2012) 1.43
Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort. Int J Cancer (2006) 1.43
Prediagnostic leptin, adiponectin, C-reactive protein, and the risk of postmenopausal breast cancer. Cancer Prev Res (Phila) (2013) 1.29
Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women. Cancer Res (2011) 1.28
A liquid chromatography-mass spectrometry method for the quantitative analysis of urinary endogenous estrogen metabolites. Nat Protoc (2007) 1.28
Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study. Breast Cancer Res (2013) 1.21
Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer. BMC Cancer (2005) 1.21
Estrogen metabolism and breast cancer risk among postmenopausal women: a case-cohort study within B~FIT. Carcinogenesis (2013) 1.13
Metabolic syndrome and postmenopausal breast cancer: systematic review and meta-analysis. Menopause (2013) 1.06
Fecal microbiota diversity in survivors of adolescent/young adult Hodgkin lymphoma: a study of twins. Br J Cancer (2013) 0.97
C-reactive protein and postmenopausal breast cancer risk: results from the E3N cohort study. Cancer Causes Control (2014) 0.96
Diversity and composition of the adult fecal microbiome associated with history of cesarean birth or appendectomy: Analysis of the American Gut Project. EBioMedicine (2014) 0.95
Genome-wide association study of circulating estradiol, testosterone, and sex hormone-binding globulin in postmenopausal women. PLoS One (2012) 0.95
Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. J Transl Med (2012) 0.94
Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones. J Steroid Biochem (1984) 0.93
Assessment of the human faecal microbiota: I. Measurement and reproducibility of selected enzymatic activities. Eur J Clin Invest (2012) 0.92
Preoperative serum C-reactive protein levels and early breast cancer by BMI and menopausal status. Cancer Invest (2013) 0.92
Overview of breast cancer collaborative stage data items--their definitions, quality, usage, and clinical implications: a review of SEER data for 2004-2010. Cancer (2014) 0.91
Associations between aromatase CYP19 rs10046 polymorphism and breast cancer risk: from a case-control to a meta-analysis of 20,098 subjects. PLoS One (2013) 0.90
Estrogen metabolism and breast cancer. Cancer Lett (2014) 0.89
Breast cancer risk in metabolically healthy but overweight postmenopausal women. Cancer Res (2015) 0.89
Enterohepatic recirculation of oestriol studied in cholecystectomized and non-cholecystectomized menopausal women. Ups J Med Sci (1984) 0.85
A prospective follow-up study of the relationship between C-reactive protein and human cancer risk in the Chinese Kailuan Female Cohort. Cancer Epidemiol Biomarkers Prev (2014) 0.85
Associations of the fecal microbiome with urinary estrogens and estrogen metabolites in postmenopausal women. J Clin Endocrinol Metab (2014) 0.85
Feasibility of self-collection of fecal specimens by randomly sampled women for health-related studies of the gut microbiome. BMC Res Notes (2014) 0.83
Circulating estrogen metabolites and risk of breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2014) 0.79
Asymmetry in family history implicates nonstandard genetic mechanisms: application to the genetics of breast cancer. PLoS Genet (2014) 0.78
Risk factors for breast cancer. Obstet Gynecol Clin North Am (2002) 0.78